← All tickers

Is LAB Worth Buying in 2026?

Standard BioTools Inc. Common Stock

STOCK LABORATORY ANALYTICAL INSTRUMENTS Updated 2026-05-03

Here’s whether Standard BioTools Inc. Common Stock (LAB) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: RSI 57 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-5.08% over 10 days); weak 1-year return of -15.7%; 3-month momentum negative (-33.6%). Currently 45.6% off its 52-week high. Score: -5/7.

Ready to act on this? 📈 Trade on Webull

LAB is trading below its 200-day MA ($1.25) — a key warning sign the longer-term trend is under pressure. An RSI of 57.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -15.7% compares to +27.9% for SPY (trailed the market by 43.6%). The current 45.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $8,428 today
vs. S&P 500 (SPY) — same period trailed market by 43.6%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($1.25)
✗Above 50-day MA ($0.97)
✓RSI(14) neutral zone (30–70) — currently 57.0
✗Positive return (-15.7%)
!Within 10% of period high (−45.6%)
Period Range $0.94
$0.87 $1.72
RSI (14) 57.0
0 · OversoldOverbought · 100

Key Metrics

Price$0.94
Period Return-15.7%
Period High$1.72
Period Low$0.87
Drawdown−45.6%
MA-50$0.97
MA-200$1.25
RSI (14)57.0
Avg Volume (30d)2.8M
vs. SPYtrailed by 44.8%
Return Rank#866 of 1236

Trade LAB

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers